Scrip Deals Podcast: An Interview With Jeremy Levin

Ovid Therapeutics Chairman Jeremy Levin talks with Scrip about how the US should view its biotech sector as a strategic national asset and urges the venture capital sector to place more emphasis on supporting early and innovative science.

Episode metadata supplied by the publisher feed · Published May 18, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Scrip Deals Podcast: An Interview With Jeremy Levin

0:00 46:19

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Citeline Podcasts?

This episode is 46 minutes long.

When was this Citeline Podcasts episode published?

This episode was published on May 18, 2026.

Can I download this Citeline Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!